Valuation : Hologic, Inc.

Market Cap 16.97B 14.6B 13.74B 12.55B 23.48B 1,602B 23.54B 162B 63B 822B 63.72B 62.33B 2,648B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 14.96B 14.08B 12.86B 24.06B 1,642B 24.12B 166B 64.56B 842B 65.3B 63.88B 2,714B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+0.45%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/26 Issuer sale

Director

19,583 0.0088%
7/4/26 Issuer sale

General Counsel

72,500 0.0325%
7/4/26 Issuer sale

Executive/Senior Manager

123,246 0.0552%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+14.49%+1.18% 16.97B
-0.75%-1.35%+25.39%+10.15% 229B
-1.60%-3.89%+4.34%-21.81% 148B
-0.85%-1.58%-19.32%+18.13% 131B
+1.81%+2.05%-55.45%-10.85% 68.04B
+0.13%-0.34%+11.04%+17.70% 51.75B
+0.49%-1.32%-17.27%-14.42% 50.21B
+0.59%-1.94%+17.42%+23.75% 42.28B
-1.01%-1.28%+36.60%+45.68% 40.63B
-0.37%-4.98%-16.60%+43.44% 33.06B
Average -0.05%-1.58%+0.06%+11.30% 81.06B
Weighted average by Cap. -0.38%-1.61%+2.19%+6.45%

Financials

2024 2025
Net sales 4.03B 3.47B 3.26B 2.98B 5.58B 381B 5.59B 38.56B 14.96B 195B 15.13B 14.8B 629B 4.1B 3.53B 3.32B 3.03B 5.67B 387B 5.69B 39.23B 15.22B 199B 15.4B 15.06B 640B
Net income 790M 679M 639M 584M 1.09B 74.54B 1.1B 7.55B 2.93B 38.24B 2.96B 2.9B 123B 566M 487M 458M 418M 783M 53.41B 785M 5.41B 2.1B 27.4B 2.12B 2.08B 88.28B
Net Debt 321M 276M 260M 238M 445M 30.34B 446M 3.07B 1.19B 15.56B 1.21B 1.18B 50.14B 421M 362M 341M 311M 582M 39.74B 584M 4.03B 1.56B 20.39B 1.58B 1.55B 65.68B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock